Metabolism of a novel CCK-B antagonist in rat, dog and human liver microsomes

Xenobiotica

Volumn 28, Issue 2, 1998, Pages 167-178

  Kajbaf, M ^a   Rossato, P ^a   Barnaby, J R ^a   Pellegatti, M ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DRUG METABOLITE; GV 150013X; N (1 ADAMANTANE 1 METHYL 2,4 DIOXO 5 PHENYL 2,3,4,5 TETRAHYDRO 1H 1,5 BENZODIAZEPIN 3 YL) N' PHENYLUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN;

ADAMANTANE; ADULT; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; FEMALE; HUMANS; HYDROXYLATION; MALE; MASS SPECTROMETRY; MICROSOMES, LIVER; MIDDLE AGED; MOLECULAR STRUCTURE; PHENYLUREA COMPOUNDS; RATS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031938240     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239669     Document Type: Article

References (19)

1. AMSTERDAM VAN, F.TH.M., OLIOSI, B., CORSI, M., RATTI, E. A., GAVIRAGHI, G. and TRIST, D. G., 1995, Receptor binding characteristics of the selective CCK-B antagonist GV150013. British Journal of Pharmacology, 116 (Proceedings supplement), 240p.
2. CHEN, W. U., DORLEY, J. M., RAMJIT, H. G., PITZENBERGER, S. M. and LIN, J. H., 1992, Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals. Drug Metabolism and Disposition, 20, 390-395.
3. CHENG, K. N., ROSANKIEWICZ, J., TRACEY, B. M. and CHALMERS, R. A., 1989, Characterization of acylcarnitines as their isobutyl ester derivatives using fast atom bombardment mass spectrometry and constant neutral loss scan. Biomedical and Environmental Mass Spectrometry, 18, 668-672.
4. CORSI, M., DAL FOMO, G., AMSTERDAM VAN, F.TH.M., FERIANI, A., URSINI, A., RATTI, E., GAVIRAGHI, G. and TRIST, D. G., 1995, The characterisation in functional assays of GV150013: a novel CCK-B receptor antagonist. British Journal of Pharmacology, 114 (Proceedings supplement), 91.
5. FINIZIA, G., DONATI, D., OLIOSI, B., TRANQUILLINI, M. E. and URSINI, A., 1996, Synthesis and evaluation of novel 1,5-benzodiazepines as potent and selective CCK-B ligands. Effects of the substitution of the N-5 phenyl with alkyl groups. Bioorganic and Medicinal Chemistry Letters, 6, 2957-2962.
6. GORROD, J. W., TEMPLE, D. J. and BECKETT, A. H., 1975, The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas-liquid chromatography. Xenobiotica, 5, 453-462.
7. KAJBAF, M., SEPAI, O., LAMB, J. H. and NAYLOR, S., 1992, Identification of metabolites of 4,4′-diaminodiphenylmethane (methylene dianiline) using liquid chromatographic and mass spectrometric techniques. Journal of Chromatography, 583, 63-76.
8. LEE, M. S. and YOST, R. A., 1988, Rapid identification of drug metabolites with tandem mass spectrometry. Biomedical and Environmental Mass Spectrometry, 15, 193-204.
9. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
10. NAKAOKA, M., TSUMURA, M., ICHIKAWA, E., SUZUKI, W., HAKUSUI, H. and NAKAZAWA, T., 1996, Identification of major biliary and urinary metabolites of ecabapide in rats. Xenobiotica, 26, 983-994.
11. NAYLOR, S., KAJBAF, M., LAMB, J. H., JAHANSHAHI, M. and GORROD, J. W., 1993, An evaluation of tandem mass spectrometry in drug metabolism studies. Biological Mass Spectrometry, 22, 388-394.
12. OGUNBIYI, O., KAJBAF, M., LAMB, J. H., JAHANSHAHI, M., GORROD, J. W. and NAYLOR, S., 1995, Characterization of 2-amino-1-benzylbenzimidazole and its metabolites using tandem mass spectrometry. Toxicology Letters, 78, 25-33.
13. OMURA, T. and SATO, R., 1962, A new cytochrome in liver microsomes. Journal of Biological Chemistry, 237, 1375-1376.
14. PERCHALSKI, R. J., YOST, R. A. and WILDER, B. J., 1982, Structure elucidation of drug metabolites by triple-quadrupole mass spectrometry. Analytical Chemistry, 54, 1466-1471.
15. REGGIANI, A., GERRARD, P. A., MARAIA, G., MELOTTO, S., RATTI, E., GAVIRAGHI, G. and TRIST, D. G., 1995, Anxiolytic activity of GV150013, a new potent and selective cholecystokinin-B (CCK-B) antagonist. British Journal of Pharmacology, 114 (Proceedings supplement), 92.
16. STRAUB, K. M. and LEVANDOSKI, P. L., 1985, Quantitative analysis of an N-oxide metabolite by fast atom bombardment tandem mass spectrometry. Biomedical Mass Spectrometry, 12, 338-343.
17. STRAUB, K. M., RUDEWICZ, P. and GARVIE, C., 1987, 'Metabolite mapping' of drugs: rapid screening techniques for xenobiotic metabolites with MS/MS techniques. Xenobiotica, 17, 413-422.
18. TRIST, D. G. and REGGIANI, A., 1996, Cholecystokinin-B (CCK-B) receptor antagonists and anxiety. Pharmacology Review and Communications, 8, 1-8.
19. WILLIAMS, J. A., 1982, Cholecystokinin: a hormone and a neurotransmitter. Biomedical Research, 3, 107-121.